Ignite Creation Date:
2025-12-25 @ 3:39 AM
Ignite Modification Date:
2026-02-27 @ 7:06 PM
Study NCT ID:
NCT03370302
Status:
TERMINATED
Last Update Posted:
2023-02-08
First Post:
2017-12-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of TAK-228 as Single Agent in Adult East Asian Participants With Advanced Nonhematological Malignancies
Sponsor:
Calithera Biosciences, Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-01-17
Start Date Type:
ACTUAL
Primary Completion Date:
2019-08-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-08-28
Completion Date Type:
ACTUAL
First Submit Date:
2017-12-07
First Submit QC Date:
None
Study First Post Date:
2017-12-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2020-08-20
Results First Submit QC Date:
None
Results First Post Date:
2020-09-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-06
Last Update Post Date:
2023-02-08
Last Update Post Date Type:
ACTUAL